Clinical Trial Update: PDE5i Use in Renal Transplant Recipients [NA]

View source ↗

Summary

A clinical trial evaluating PDE5 inhibitors in renal transplant recipients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Failure

Drugs mentioned

• PDE5 inhibitors

Snippet

Sponsor: University of British Columbia | Conditions: Renal Transplant Failure | NA | Status: WITHDRAWN